AN2 THERAPEUTICS, INC.

Profile

Company Names

AN2 THERAPEUTICS, INC.

Addresses

1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA 94025

Phone Numbers

(650) 331-9090

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$39,999,989.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2026-03-10 
$39,999,989.00 
$39,999,989.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KABEER 
 
AZIZ 
DIRECTOR
AN2 THERAPEUTICS, INC.
SANJAY 
 
CHANDA 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS, INC.   |  AN2 THERAPEUTICS, INC.
LUCY 
 
DAY 
EXECUTIVE OFFICER
AN2 THERAPEUTICS, INC.
ERIC 
 
EASOM 
EXECUTIVE OFFICER, DIRECTOR
AN2 THERAPEUTICS, INC.
JOSHUA 
 
EIZEN 
EXECUTIVE OFFICER
AN2 THERAPEUTICS, INC.
MARGARET 
 
FITZPATRICK 
DIRECTOR
AN2 THERAPEUTICS, INC.
GILBERT 
LYNN 
MARKS 
DIRECTOR
AN2 THERAPEUTICS, INC.
PATRICIA 
 
MARTIN 
DIRECTOR
LEAP THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
ROB 
 
READNOUR 
DIRECTOR
APPLIED LIFESCIENCES + SYSTEMS POULTRY, INC.   |  AN2 THERAPEUTICS, INC.
MELVIN 
 
SPIGELMAN 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  AN2 THERAPEUTICS, INC.
STEPHANIE 
 
WONG 
DIRECTOR
AGRIOS GLOBAL HOLDINGS LTD.   |  AN2 THERAPEUTICS, INC.
JOSEPH 
S. 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ACCELERON PHARMA INC   |  INVESTABLE EMERGING MARKETS COUNTRY FUND   |  EMERGING (FREE) MARKETS COUNTRY FUND   |  GLIACURE, INC.   |  EMERGING MARKETS COUNTRY FUND   |  CERECIN INC.   |  CYTEIR THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-03-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011